High RF energy ablation of atrial fibrillation is fast, safe, less painful and effective procedure.
Atrial fibrillation (AF) ablation is the most commonly performed radiofrequency (RF) ablation and is usually associated with a long procedural time and sensation of pain in conscious patients. Prolonged radiation exposure during the procedure puts the patient and the operator at risk of malignancy and genetic abnormalities. Complications such as asymptomatic cerebral lesions, tamponade, perforation, and also arrhythmia recurrence were associated with longer ablation time. High-power, shorter-duration radiofrequency ablation (HPSDRFA) appears to be a novel concept for atrial fibrillation (AF) but there are scarce data in conscious patients. The lesion side index (LSI) value has been associated with durability of pulmonary vein isolation (PVI) lesions. We hypothesised that HPSDRFA applications based on the lesion side index (LSI; its has been associated with durability of pulmonary vein isolation (PVI) lesions) which were not inferior to standard approach regarding safety and effectiveness with shorten procedure time and being less painful for a patient.
Study Type
OBSERVATIONAL
Enrollment
30
Comparison of standard, 40W and 50W RF energy setting for ablation of atrial fibrillation
Medical University of Lublin
Lublin, Poland
Procedure time:
Total procedure time (needle to needle time).
Time frame: procedure
Left atrial dwelling time
time of left atrium instrumentation
Time frame: transeptal access to removal of a catheter and a sheath
Voltage mapping time
time needed to perform 3D electroanatomical map and high density voltage mapping of left atrium.
Time frame: procedure
Total RF time
time of all performed radiofrequency (RF) applications
Time frame: procedure
Total number of RF applications
number of all RF applications performed during a procedure
Time frame: procedure
X-Ray time
the total time of fluoroscopy
Time frame: procedure
Complications
both procedure-related complications and all complications in 12 moths follow-up as follows: Cardiac tamponade/perforation \[yes/no\], Stroke/TIA (Transient ischemic attack) \[yes/no\], Oesophageal injury (perforation/fistula) \[yes/no\], Death (procedural related, one year follow up) \[yes/no\], Stem pops \[yes/no\], Catheter char \[yes/no\], Phrenic nerve paralysis \[yes/no\], PV stenosis requiring intervention \[yes/no\], Gastrointestinal bleeding or gastrointestinal complaints \[yes/no\], Need for periprocedural pacemaker implantation \[yes/no\], Vascular access complication which required intervention \[yes/no\], Vascular access complication which not required intervention \[yes/no\],
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Time frame: 12 months
Number of stopped RF applications as a result of pain complained by a patient
the surrogate for assessment of the painfulness of the procedure
Time frame: procedure
Follow-up-30s
absence any arrhythmia recurrence (AR) defined as any documented recurrence of AF and/or atrial tachycardia (AT) and /or atrial flutter (AFL) lasting longer than 30 second
Time frame: procedure